Nautilus Biotechnology, Inc.
NASDAQ:NAUT · NASDAQ Global Select
+$0.05 today
Vol 0.48M · Avg 0.40M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+228.01%
Period High
$3.95
Period Low
$0.64
Latest
$2.28
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$385.88M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$290.21M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$241.90M
Zura Bio Limited
NASDAQ:ZURA
$238.63M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$216.51M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$211.47M
Immuneering Corporation
NASDAQ:IMRX
$156.64M
Humacyte, Inc.
NASDAQ:HUMA
$155.90M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$117.06M
What is the latest NAUT filing?
The latest filing shown is SC 13D/A dated Jun 4, 2026.
How many recent filings does NAUT have?
Intrinsic Alpha currently shows 20 recent filings for NAUT.
Explore More
Continue the stock analysis
Jump to another research area for this company.